G&E Herbal Biotechnology Co., Ltd.

NT$25.00As of Sun 8 Nov 2026, 12:00 UTC
TPEx:4911Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR (8.92%)
Div yield 4.32%
ROE 6.21%
Biotechnology
Beta (5Y) (0.68)
PE TTM 30.98
TSR TTM (43.07%)
Mkt cap NT$1.720B
ROIC 9.37%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$31
25.83%
(6.76%)
Hold 11|10|9|11|10
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.58
0.63
0.68
0.72
12.93%
19.19%
33.30%
35.19%
RevenueNT$M
119.4
126.3
130.5
130.0
4.12%
5.33%
11.39%
13.97%
Peers (US$51.96M)
Cap (US$)
PE
46.65M
10.90x
52.12M
—
Capital
TTM
5Y
10Y
Leveragex
0.436
0.677
0.562
EBIT/Intx
0.538
0.241
0.241
Own earn%
(10.45)
62.86
75.40
Sh yield%
34.62
43.91
42.55
Owners
Insiders/Inst%
3.82
54.07
Short interest%
2.28
SBC / revenue%
5.61
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
17–23
$1 testx
—
Incr. ROIC%
5